AVIVA PLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
AVIVA PLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$3,612,202
-70.3%
87,041
-57.0%
0.02%
-72.7%
Q1 2023$12,169,869
-17.2%
202,359
+1.0%
0.06%
-23.6%
Q4 2022$14,701,541
+143.2%
200,430
+151.9%
0.07%
+105.7%
Q3 2022$6,045,000
-20.3%
79,559
-27.1%
0.04%
-12.5%
Q2 2022$7,581,000
+244.6%
109,075
+310.8%
0.04%
+263.6%
Q1 2022$2,200,000
-3.9%
26,551
-12.9%
0.01%
+10.0%
Q4 2021$2,289,000
-37.0%
30,482
-2.6%
0.01%
-37.5%
Q3 2021$3,634,000
-57.8%
31,284
-19.4%
0.02%
-57.9%
Q2 2021$8,613,000
+49.2%
38,830
-11.1%
0.04%
+35.7%
Q1 2021$5,773,000
+142.8%
43,672
+217.8%
0.03%
+133.3%
Q4 2020$2,378,000
-2.4%
13,742
-37.2%
0.01%
-14.3%
Q3 2020$2,437,000
+3.8%
21,896
-44.7%
0.01%
-6.7%
Q2 2020$2,347,000
-35.5%
39,581
-26.8%
0.02%
-44.4%
Q1 2020$3,640,00054,0570.03%
Other shareholders
NOVOCURE LTD shareholders Q1 2020
NameSharesValueWeighting ↓
StepStone Group LP 1,365,479$29,767,00021.90%
Tamarack Advisers, LP 1,115,000$24,307,00011.56%
COURAGE CAPITAL MANAGEMENT LLC 275,000$5,995,0004.57%
GREAT POINT PARTNERS LLC 753,481$16,426,000,0002.44%
HARTLINE INVESTMENT CORP/ 404,052$8,808,0002.42%
Pier Capital, LLC 346,350$7,550,0001.29%
Rhenman & Partners Asset Management AB 435,000$9,483,0001.17%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,029,910$22,452,0000.77%
PEREGRINE CAPITAL MANAGEMENT LLC 922,468$20,110,0000.49%
Hodges Capital Management Inc. 285,500$6,224,0000.49%
View complete list of NOVOCURE LTD shareholders